Designates third full week in April of each year as "Infertility Awareness Week" in New Jersey.
Impact
The resolution highlights important statistics from the Centers for Disease Control and Prevention, noting that infertility affects approximately nine percent of men and eleven percent of women in the United States. By declaring this week, the resolution not only aims to educate the public but also to initiate supportive outreach programs that can alleviate the stigma surrounding infertility. The effects of infertility can include emotional distress and financial strain; therefore, promoting awareness can facilitate better community support for affected individuals.
Summary
AJR65 is a Joint Resolution introduced in the New Jersey legislature that aims to designate the third full week in April each year as 'Infertility Awareness Week.' This initiative is intended to raise awareness about infertility issues, which affect a significant portion of the population, with one in eight couples experiencing difficulties in conceiving. Given that infertility impacts both men and women, the resolution seeks to broaden public understanding and promote discussions around the emotional and psychological challenges that accompany such experiences.
Contention
While AJR65 itself is not likely to encounter significant contention as it primarily serves an awareness purpose, discussions surrounding infertility can sometimes lead to debates over health care policies, insurance coverage for fertility treatments, and access to psychological resources. The resolution emphasizes the importance of empathy for couples facing infertility, which highlights a need for increased access to services, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), generally associated with high costs. This aspect may raise discussions on legislative efforts to ensure better healthcare coverage for such treatments in New Jersey.
Requires individual and group health insurance policies that provide pregnancy-related benefits to cover medically necessary expenses for diagnosis and treatment of infertility and standard fertility-preservation services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Requires health insurance coverage of standard fertility preservation services for individuals with certain menstrual disorders resulting in infertility.